Venousonics Ltd.
This article was originally published in Start Up
Executive Summary
Venousonics hopes to be the first company to launch a completely non-invasive technology for treating varicose veins, and eventually smaller veins as well. It is delivering highly-focused ultrasound through the skin to induce cavitation. The ensuing microbubbles explode and destroy the vein wall, resulting in vessel closure. The Israeli company aims to provide fast, effective and pain-free relief of venous reflux.
You may also be interested in...
New Devices for Varicose Veins
There's nothing even remotely sexy about varicose veins. Yet medical device companies and their investors are starting to view the opportunity for treating these bulging blue leg veins as downright alluring. The recent introduction of minimally invasive technologies, combined with shifting demographics and favorable reimbursements, are fueling talk of blockbuster potential for this hybrid clinical/cosmetic market.
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.